Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 02, 2023

SELL
$7.31 - $11.18 $251,866 - $385,206
-34,455 Reduced 18.99%
146,948 $1.11 Million
Q4 2022

Jan 30, 2023

BUY
$9.48 - $14.52 $343,725 - $526,466
36,258 Added 24.98%
181,403 $1.84 Million
Q3 2022

Nov 08, 2022

BUY
$9.2 - $13.68 $16,053 - $23,871
1,745 Added 1.22%
145,145 $1.44 Million
Q2 2022

Aug 04, 2022

BUY
$5.72 - $10.65 $820,248 - $1.53 Million
143,400 New
143,400 $1.53 Million
Q1 2022

May 05, 2022

SELL
$7.46 - $14.14 $1.18 Million - $2.25 Million
-158,847 Closed
0 $0
Q2 2021

Aug 02, 2021

BUY
$20.19 - $34.17 $3.21 Million - $5.43 Million
158,847 New
158,847 $3.5 Million

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $841M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.